Therapeutic treatment of fibromyalgia

Details Therapeutic treatment of fibromyalgia Therapeutic treatment of fibromyalgia

1992-09-21

1995-01-03

Wityshyn, Michael G.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

530399, A61K 3736

Patent

active

053786866

ABSTRACT:
Disclosed is a therapeutic regime for treating patients with fibromyalgia (FM) and other syndromes characterized by non-restorative sleep and musculoskeletal pain. Supplemental growth hormone (GH) is administered and somatomedin-C (SMC) levels monitored until SMC levels reach optimal levels and musculoskeletal pain and fatiguability symptoms subside.

REFERENCES:
patent: 4816439 (1989-03-01), Jorgensen
Bennett et al., "Low Somatomedin-C levels in Fibromyalgia" abstract, Arthritis Rheum 34 (9 Suppl.), p. 5188 (1991).
Astrom, C. et al., "Sleep in Acromegaly before & after treatment . . . ", Neuroendocrinology, vol. 53 (4), pp. 328-331 (1991).
Bennett, J. of Rheumatology, 16:185-191 (1989).
Bennett et al., Arthritis and Rheumatism, 35:1113-1116 (1992).

Affiliated with

Also associated with

Rating

Therapeutic treatment of fibromyalgia does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Therapeutic treatment of fibromyalgia, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapeutic treatment of fibromyalgia will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2211520